包涵体：新概念。
Inclusion bodies: a new concept.
机构信息
CIBER en Bioingeniería, Biomateriales y Nanomedicina, Bellaterra, 08193 Barcelona, Spain.
出版信息
Microb Cell Fact. 2010 Nov 1;9:80. doi: 10.1186/1475-2859-9-80.
Abstract
In the last decades, the understanding of inclusion body biology and consequently, of their properties and potential biotechnological applications have dramatically changed. Therefore, the development of new purification protocols aimed to preserve those properties is becoming a pushing demand.
摘要
在过去几十年中，人们对包涵体生物学的理解以及由此产生的对其性质和潜在生物技术应用的理解发生了巨大变化。因此，开发旨在保留这些特性的新纯化方案成为一种迫切需求。
相似文献
1
Inclusion bodies: a new concept.
Microb Cell Fact. 2010 Nov 1;9:80. doi: 10.1186/1475-2859-9-80.
2
High-throughput recovery of therapeutic proteins from the inclusion bodies of Escherichia coli: an overview.
Methods Mol Biol. 2005;308:155-61. doi: 10.1385/1-59259-922-2:155.
3
Isolation, solubilization, refolding, and chromatographic purification of human growth hormone from inclusion bodies of Escherichia coli cells: a case study.
Methods Mol Biol. 2005;308:163-76. doi: 10.1385/1-59259-922-2:163.
4
Bioprocessing of therapeutic proteins from the inclusion bodies of Escherichia coli.
Adv Biochem Eng Biotechnol. 2003;85:43-93. doi: 10.1007/3-540-36466-8_3.
5
Active inclusion body formation using Paenibacillus polymyxa PoxB as a fusion partner in Escherichia coli.
Anal Biochem. 2012 Jul 1;426(1):63-5. doi: 10.1016/j.ab.2012.04.002. Epub 2012 Apr 7.
6
Functional protein aggregates: just the tip of the iceberg.
Nanomedicine (Lond). 2015;10(18):2881-91. doi: 10.2217/nnm.15.125. Epub 2015 Sep 15.
7
Microfluidic chips with multi-junctions: an advanced tool in recovering proteins from inclusion bodies.
Bioengineered. 2015;6(1):1-4. doi: 10.4161/21655979.2014.987022. Epub 2015 Jan 7.
8
Expression, Solubilization, Refolding and Final Purification of Recombinant Proteins as Expressed in the form of "Classical Inclusion Bodies" in .
Protein Pept Lett. 2021;28(2):122-130. doi: 10.2174/0929866527999200729182831.
9
[Solubilization Specificities Interferon beta-1b from Inclusion Bodies].
Bioorg Khim. 2015 Jul-Aug;41(4):403-10. doi: 10.1134/s1068162015040159.
10
Refolding, purification, and activation of miniplasminogen and microplasminogen isolated from E. coli inclusion bodies.
Protein Expr Purif. 2007 Apr;52(2):395-402. doi: 10.1016/j.pep.2006.10.012. Epub 2006 Oct 26.
引用本文的文献
1
State-of-the-art and novel approaches to mild solubilization of inclusion bodies.
Front Bioeng Biotechnol. 2023 Jul 20;11:1249196. doi: 10.3389/fbioe.2023.1249196. eCollection 2023.
2
Implementation of a Design of Experiments to Improve Periplasmic Yield of Functional ScFv Antibodies in a Phage Display Platform.
Adv Pharm Bull. 2022 May;12(3):583-592. doi: 10.34172/apb.2022.061. Epub 2021 Jul 3.
3
Fundamental insights in early-stage inclusion body formation.
Microb Biotechnol. 2023 May;16(5):893-900. doi: 10.1111/1751-7915.14117. Epub 2022 Jul 13.
4
In Vivo Bactericidal Efficacy of GWH1 Antimicrobial Peptide Displayed on Protein Nanoparticles, a Potential Alternative to Antibiotics.
Pharmaceutics. 2020 Dec 17;12(12):1217. doi: 10.3390/pharmaceutics12121217.
5
Optimization of Methods for the Production and Refolding of Biologically Active Disulfide Bond-Rich Antibody Fragments in Microbial Hosts.
Antibodies (Basel). 2020 Aug 5;9(3):39. doi: 10.3390/antib9030039.
6
Production of Active Recombinant Hyaluronidase Inclusion Bodies from in Bl21(DE3) and characterization by FT-IR Spectroscopy.
Int J Mol Sci. 2020 May 29;21(11):3881. doi: 10.3390/ijms21113881.
7
Solubilization of Human Interferon β-1b Inclusion Body Proteins by Organic Solvents.
Adv Pharm Bull. 2020 Jun;10(2):233-238. doi: 10.34172/apb.2020.027. Epub 2020 Feb 18.
8
Improvement of solubility and yield of recombinant protein expression in using a two-step system.
Res Pharm Sci. 2019 Oct 4;14(5):400-407. doi: 10.4103/1735-5362.268200. eCollection 2019 Oct.
9
Fish Red Blood Cells Modulate Immune Genes in Response to Bacterial Inclusion Bodies Made of TNFα and a G-VHSV Fragment.
Front Immunol. 2019 May 22;10:1055. doi: 10.3389/fimmu.2019.01055. eCollection 2019.
10
Recombinant production of ESAT-6 antigen in thermoinducible Escherichia coli: the role of culture scale and temperature on metabolic response, expression of chaperones, and architecture of inclusion bodies.
Cell Stress Chaperones. 2019 Jul;24(4):777-792. doi: 10.1007/s12192-019-01006-x. Epub 2019 Jun 4.
本文引用的文献
1
Isolation of cell-free bacterial inclusion bodies.
Microb Cell Fact. 2010 Sep 17;9:71. doi: 10.1186/1475-2859-9-71.
2
Isolation of biologically active nanomaterial (inclusion bodies) from bacterial cells.
Microb Cell Fact. 2010 Sep 10;9:66. doi: 10.1186/1475-2859-9-66.
3
Side effects of chaperone gene co-expression in recombinant protein production.
Microb Cell Fact. 2010 Sep 2;9:64. doi: 10.1186/1475-2859-9-64.
4
Nanotechnology, bionanotechnology and microbial cell factories.
Microb Cell Fact. 2010 Jul 5;9:53. doi: 10.1186/1475-2859-9-53.
5
The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation.
Biomaterials. 2010 Aug;31(22):5805-12. doi: 10.1016/j.biomaterials.2010.04.008. Epub 2010 May 8.
6
Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering.
Nanotechnology. 2010 May 21;21(20):205101. doi: 10.1088/0957-4484/21/20/205101. Epub 2010 Apr 23.
7
Protein-engineered biomaterials: highly tunable tissue engineering scaffolds.
Tissue Eng Part B Rev. 2010 Jun;16(3):285-93. doi: 10.1089/ten.teb.2009.0591.
8
Nanotechnology for bone materials.
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009 May-Jun;1(3):336-51. doi: 10.1002/wnan.23.
9
Carrier-free immobilized enzymes for biocatalysis.
Biotechnol Lett. 2010 Mar;32(3):341-50. doi: 10.1007/s10529-009-0173-4. Epub 2009 Nov 27.
10
Targeting lectin activity into inclusion bodies for the characterisation of glycoproteins.
Mol Biosyst. 2009 Aug;5(8):819-21. doi: 10.1039/b900526a. Epub 2009 Jun 23.
Zotero 插件